MicroStrategy
MSTR
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
Coinbase
COIN
US Stock MarketDetailed Quotes
RXRX Recursion Pharmaceuticals
- 7.570
- +0.110+1.47%
Close Dec 11 16:00 ET
- 7.700
- +0.130+1.72%
Post 19:59 ET
2.17BMarket Cap-4.92P/E (TTM)
7.890High7.230Low14.75MVolume7.890Open7.460Pre Close110.81MTurnover5.74%Turnover RatioLossP/E (Static)286.64MShares15.74052wk High4.14P/B1.95BFloat Cap5.60052wk Low--Dividend TTM257.07MShs Float42.810Historical High--Div YieldTTM8.85%Amplitude4.540Historical Low7.513Avg Price1Lot Size
About Recursion Pharmaceuticals Company
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.
Company Profile
SymbolRXRX
Company NameRecursion Pharmaceuticals
Listing DateApr 16, 2021
Issue Price18.00
Founded2013
CEODr. Christopher Gibson, PhD
MarketNASDAQ
Employees500
Fiscal Year Ends12-31
Address41 South Rio Grande Street
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84101
Phone1-385-269-0203
Websitehttp://www.recursion.com
Company Executives
- Name
- Position
- Salary
- Dr. Christopher Gibson, PhD
- Chief Executive Officer, Director and President
- 8.61M
- Kristen Rushton
- Chief Operating Officer
- --
- Matthew Kinn
- Chief Business Officer
- --
- Ben R. Taylor
- Chief Financial Officer and President, Recursion UK
- --
- Dr. Najat Khan, PhD
- Director, Chief Research and Development Officer and Chief Commercial Officer
- --
- David Hallett, PhD
- Chief Scientific Officer
- --
- Dr. David J. Mauro, M.D.
- Chief Medical Officer
- 4.31M
- Lina Nilsson
- Senior Vice President and Head, Platform
- --
- Dr. Robert M. Hershberg, M.D.,PhD
- Chairman of the Board
- 302.74K
- Dr. Franziska Michor, PhD
- Director
- --
- Zavain Dar, PhD
- Independent Director
- 307.74K
- Dr. Blake Borgeson, PhD
- Independent Director
- 292.74K
- Dean Y. Li, M.D.,PhD
- Independent Director
- 300.25K
- Zachary Bogue, J.D.
- Independent Director
- 21.25K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
